UNITY Biotechnology to Participate in the SVB Securities Global Biopharma Conference
UNITY Biotechnology [NASDAQ: UBX] has scheduled a corporate update and one-on-one investor meetings at the SVB Securities Global Biopharma Conference on February 15, 2023, at 11:20 AM ET. The company focuses on developing therapeutics to address diseases of aging, particularly targeting age-related ophthalmologic and neurologic diseases by eliminating or modulating senescent cells. The presentation will be accessible via webcast and can also be found on their website under the 'Investors and Media' section.
- None.
- None.
SOUTH SAN FRANCISCO, Calif., Feb. 15, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that the Company’s Management will provide a corporate update and participate in one-on-one investor meetings at the SVB Securities Global Biopharma Conference on Wednesday, February 15, 2023 at 11:20 AM ET.
The webcast of the presentation will be accessible here and through the “Investors and Media” section of our website, www.unitybiotechnology.com, under “Events & Presentations.”
About UNITY
UNITY is developing a new class of therapeutics to slow, halt or reverse diseases of aging. UNITY’s current focus is on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related ophthalmologic and neurologic diseases. More information is available at www.unitybiotechnology.com or follow us on Twitter and LinkedIn.
FAQ
What is the purpose of UNITY's participation in the SVB Securities Global Biopharma Conference?
When is UNITY's presentation at the SVB Securities Global Biopharma Conference?
How can I access UNITY's conference presentation?
What does UNITY Biotechnology focus on in its research?
What is the stock symbol for UNITY Biotechnology?
